Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$335,190
+$181,877 QoQ
Shares Held
32,168
+29.0% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 95 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. RNAC ranks #273 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in RNAC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $335,190 32,168
2026-03-31 $153,313 24,929
2025-12-31 $182,413 25,300
2025-09-30 $254,426 24,895
2025-06-30 $258,742 24,903
2025-03-31 $386,213 29,303
2024-12-31 $480,041 26,803
2024-09-30 $307,053 19,048
2024-06-30 $514,486 19,048
2024-03-31 $211,450 325,308
2023-12-31 $224,137 325,308
2023-09-30 $344,826 325,308
2023-06-30 $364,344 325,308
2023-03-31 $83,116 59,796
2022-12-31 $67,569 59,796
2022-09-30 $98,065 59,796
2022-06-30 $78,332 59,796
2022-03-31 $295,550 240,285
2021-12-31 $748,831 229,703
2021-09-30 $955,564 229,703
2021-06-30 $932,821 223,163
2021-03-31 $810,155 179,040
2020-12-31 $584,023 192,747
2020-09-30 $460,154 185,546
2020-06-30 $456,788 160,841
2020-03-31 $35,333 14,661